Lung cancer cytology: Potential pitfalls and mimics - a review

International Journal of Clinical and Experimental Pathology

Volumn 3, Issue 4, 2010, Pages 367-385

  Idowu, Michael O ^a   Powers, Celeste N ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Clinical history; Lung cancer; Mimics; Non small cell carcinoma; Pitfalls; Pulmonary carcinoma; Respiratory cytology; Squamous cell carcinoma

Indexed keywords

CLASSIFICATION; CYTODIAGNOSIS; CYTOLOGY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; HUMAN; LABORATORY DIAGNOSIS; LUNG TUMOR; REVIEW;

CYTODIAGNOSIS; CYTOLOGICAL TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; LUNG NEOPLASMS;

EID: 77955863108     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. http://www.cancer.org/downloads/stt/CFF2009_LeadingSites_Est_6.pdf. Accessed February 19, 2010.
2. Thivolet-Bejui F. Cytopathological pitfalls in bronchopulmonary tumors. Diagn Cytopathol 1997; 17: 412-416.
3. Castranova V, Rabovsky J, Tucker JH and Miles PR. The alveolar type II epithelial cells: a multifunctional pneumocyte. Toxicol Appl Pharmacol 1988; 93: 472-83.
4. Grotte D, Stanley MW, Swanson PE, Henry-Stanley MJ and Davies S. Reactive type II pneumocytes in bronchoalveolar lavage fluid from adult respiratory distress syndrome can be mistaken for cells of adenocarcinoma. Diagn Cytopathol 1990; 6: 317-322.
5. Stanley MW, Henry-Stanley MJ, Gajl-Peczalska KJ and Bitterman PB. Hyperplasia of type II pneumocytes in acute lung injury. Cytologic findings of sequential bronchoalveolar lavage. Am J Clin Pathol 1992; 92: 669-677.
6. Demay RM: Respiratory cytology. The art and science of cytopathology. Volume 1. Edited by Demay RM. Chicago, ASCP Press, 1996, pp. 207-256.
7. Naryshkin S and Young NA. Respiratory cytology: A review of non-neoplastic mimics of malignancy. Diagn Cytopathol 1993; 9: 89-97.
8. Zaman SS, van Hoeven KH, Slott S and Gupta PK. Distinction between bronchioloalveolar carcinoma and hyperplastic pulmonary proliferations: a cytologic and morphometric analysis. Diagn Cytopathol 1997. 16:396-401.
9. Selvaggi SM and Gerber M. Pulmonary cytology in patients with the acquired immunodeficiency syndrome (AIDS). Diagn Cytopathol 1986; 2: 187-193.
10. MacDonald LL and Yazdi HM. Fine needle aspiration biopsy of bronchioloalveolar carcinoma. Cancer 2001; 93: 29-34.
11. Silverman JF, Finley JL, Park HK, Strausbauch P, Unverferth M and Carney M. Fine needle aspiration cytology of bronchioloalveolar cell carcinoma of the lung. Acta Cytol 1985; 29: 887-894.
12. Rogers DF. Airway mucus hypersecretion in asthma: an undervalued pathology? Current Opinion Pharmacol 2004; 4: 241-250.
13. Beskow CO, Drachenberg CB, Bourquin PM, Britt EJ, Simsir A, Gunev I and Papadimitriou JC. Diffuse alveolar damage. Morphologic features in bronchoalveolar lavage fluid. Acta Cytol 2000; 44: 640-646.
14. Scoggins WG, Smith RH, Frable WJ and O'Donohue WJ. False-positive cytological diagnosis of lung carcinoma in patients with pulmonary infarcts. Ann Thorac Surg 1977; 24: 474-480.
15. Crapanzano JP and Zakowski MF. Diagnostic dilemmas in pulmonary cytology. Cancer 2001; 93: 364-375.
16. Silverman JF. Inflammatory and neoplastic processes of the lung: differential diagnosis and pitfalls in FNA biopsies. Diagn Cytopathol 1995; 13: 448-462.
17. Naryshkin S and Bedrossian WM. Selected mimics of malignancy in sputum and bronchoscopic cytology specimens. Diagn Cytopathol 1995; 13: 443-447.
18. Koss LG, Woyke S, Olszewski W. Aspiration biopsy: cytologic interpretation and histologic bases. Edited by Koss LG, Woyke S, Olszewski W. Tokyo, Igalu-Shoin, 1984, pp. 287-349.
19. Frost JK. The cell in health and disease. Edited by Frost JK. Basel, S. Krager, 1986, pp. 110-111
20. Kline TS. Handbook of fine needle aspiration biopsy cytology. Edited by Kline TS. New York, Churchill Liningstone, 1988, pp. 253-295.
21. Saad RS and Silverman JF. Respiratory cytology: differential diagnosis and pitfalls. Diagn Cytopathol 2009; 38: 297-307.
22. Ness M, Hansen S, Armitage JO, Rennard SI, Vaughan WP, Stahl MG and Linder J. Acute effects of chemotherapy on cellular composition and cytomorphology of bronchial lavage specimens [abstract]. Acta Cytol 1987; 31: 647-648.
23. Saito Y, Imai T, Sato M, Ota S, Kanma K, Takahashi S, Usuda K, Sagawa M, Nagamoto N, Suda H and Nakada T. Cytologic study of tissue repair in human bronchial epithelium. Acta Cytol 1988; 32: 622-628.
24. Policarpio-Nicolas MLC and Wick RM. Falsepositive interpretations in respiratory cytopathology: exemplary cases and literature review. Diagn Cytopathol 2008; 36: 13-19.
25. Folpe AL. Neoplasms with perivascular epithelioid cell differentiation (PEComas). World Health Organization classification of tumors. Pathology and genetics of tumors of soft tissue and bone. Edited by Fletcher CD, Unni KK and Mertens F. Lyon, IARC Press, 2002, pp. 221-222.
26. Liebow AA and Castleman B. Benign clear cell tumors of the lung. Am J Pathol 1963; 43:13A.
27. Liebow AA and Castleman B. Benign clear cell ["sugar"] tumors of the lung. Yale J Biol Med 1971; 43: 213-222.
28. Policarpio-Nicolas ML, Covell J, Bregman S and Atkins K. Fine needle aspiration cytology of clear cell "sugar" tumor [PEComas] of the lung: report of a case. Diagn Cytopathol 2008; 36: 89-93.
29. Nguyen GK. Aspiration biopsy cytology of benign clear cell ("sugar") tumor of the lung. Acta Cytol 1989; 33: 511-515.
30. Watanabe K, Ono N, Hoshi T, Hanzawa M, Ishida T. Fine needle aspiration cytology of bronchial acinic cell carcinoma: a case report. Diagn Cytopathol 2004; 30: 359-361.
31. Hughes JH, Jensen CS, Donnelly AD, Cohen MB, Silverman JF, Geisinger KR and Raab SS. The role of fine needle aspiration cytology in the evaluation of metastatic clear cell tumors. Cancer 1999; 87: 380-389.
32. Deavers M, Guinee D, Koss MN and Travis WD. Granular cell tumor of the lung: clinicopathologic study of 20 cases. Am J Surg Pathol 1995; 19: 627-635.
33. Husain M and Nguyen GK. Cytopathology of granular cell tumor of the lung. Diagn Cytopathol 2000; 23: 294-295.
34. Azua Blanco J, Azua Romeo J, Ortego J and Perez Cach MJ. Cytologic features of pulmonary hamartoma: report of a case diagnosed by fine needle aspiration cytology. Acta Cytol 2001; 45: 267-270.
35. Hughes JH, Young NA, Wilbur DC, Renshaw AA and Mody DR. Fine needle aspiration of pulmonary hamartoma: a common source of falsepositive diagnoses in the College of American Pathologists interlaboratory comparison program in non-gynecologic cytology. Arch Pathol Lab Med 2005; 129: 19-22.
36. Dunbar F and Leiman G. The aspiration cytology of pulmonary hamartomas. Diagn Cytopathol 1989; 5: 174-180.
37. Steen-Hansen E. The diagnostic value of chest Xray combined with fine needle aspiration biopsy in patients suspected for pulmonary hamartomas. Rontgenblatter 1987; 40: 321-324.
38. Ramzy I. Pulmonary hamartomas: cytologic appearances of fine needle aspiration biopsy. Acta Cytol 1976; 20: 15-19.
39. Afify A, Zhou H, Howell L and Paulino AF. Diagnostic utility of GLUT-1 expression in cytologic evaluation of serous fluids. Acta Cytol 2005; 49: 621-626.
40. Kitazume H, Kitamura K, Mukai K, Inayama Y, Kawano N, Nakamura N, Sano J, Mitsui K, Yoshida S and Nakatani Y. Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma and adenocarcinoma: Utility of combined E-cadherin and calretinin immunostaining. Cancer 2000; 90: 55-60.
41. Davidson B, Nielsen S, Christensen J, Asschenfeldt P, Berner A, Risberg B and Johansen P. The role of desmin and N-cadherin in effusion cytology: A comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol 2001; 25: 1405-1412.
42. Hwang SJ, Cheng LS, Lozano G, Amos CI, Gu X and Strong LC. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking and cancer risk. Hum Genet 2003; 113: 238-243.
43. Sanders BM, Jay M, Draper GJ and Roberts EM. Non-ocular cancer in relatives of retinoblastoma patients. Br J Cancer 1989; 60: 358-65.
44. Bell DW, Gore I, Okimoto RA, Godin-Heymann N, Sordella R, Mulloy R, Sharma SV, Brannigan BW, Mohapatra G, Settleman J and Haber DA. Inherited susceptibility to lung cancer may be associated with T790M drug resistance mutation in EGFR. Nat Genet 2005; 37: 1315-6.
45. Herbst RS, Heymach JV and Lippman SM. Molecular Origins of Cancer: Lung Cancer. N Engl J Med 2008; 359: 1367-1380.
46. Westra WH. Early glandular neoplasia of the lung. Respir Res 2000; 1: 163-169.
47. Tang X, Shigematsu H, Bekele BN, Roth JA, Minna JD, Hong WK, Gazdar AF and Wistuba II. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. Cancer Res 2005; 65: 7568-7572.
48. Guo M, House MG, Hooker C, Han Y, Heath E, Gabrielson E, Yang SC, Baylin SB, Herman JG and Brock MV. Promoter hypermethylation of resected bronchial margins: a field defect of changes? Clin Cancer Res 2004; 10: 5131-5136.
49. Bhutani M, Pathak AK, Fan YH, Liu DD, Lee JJ, Tang H, Kurie JM, Morice RC, Kim ES, Hong Wk and Mao L. Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs. Cancer Prev Res 2008;1:39-44.
50. Licchesi JD, Westra WH, Hooker CM and Herman JG. Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung. Clin Cancer Res 2008; 14: 2570-8.
51. Salomon DS, Brandt R, Ciardiello F and Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995; 19: 183-232.
52. Sharma SV, Bell DW, Settleman J and Haber DA. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 2007; 7: 169-181.
53. Nicholson RI, Gee JM and Harper ME. EGFR and cancer prognosis. Eur J Cancer 2001; 37: S9-S15.
54. Subramanian J and Govindan R. Lung cancer in never smokers: a review. J Clin Oncol 2007; 25: 561-570.
55. Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, Mardis E, Kupfer D, Wilson R, Kris M and Varmus H. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Pro Natl Acad Sci USA 2004; 101: 13306-13311.
56. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Sipco JG, Alaska FG, Louis DN, Christiana DC, Settleman J and Haber DA. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer to gefitinib. N Engl J Med 2004; 350: 2129-2139.
57. Shih JY, Gown CH, Yu CJ, Yang Ch, Chang YL, Tsai MF, Hsu HC, Chen KY, Su WP and Yang PC. Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced non small cell lung cancer. Int J Cancer 2006; 118: 963-969.
58. Zhang X, Zhao Y, Wang M, Yap WS and Chang AY. Detection and comparison of epidermal growth factor receptor mutations in cells and fluid of malignant pleural effusion in non-small cell lung cancer. Lung cancer 2008; 60: 175-182.
59. Otani H, Toyooka S, Soh J, Yamamoto H, Suehisa H, Kobayashi N, Gobara H, Mimura H, Kiura K, Sano Y, Kanazawa S and Date H. Detection of EGFR gene mutations using the wash fluid of CT guided biopsy needle in NSCLC patients. J Thorac Oncol 2008; 3: 472-476.
60. Boldrini L, Gisfredi S, Ursino S, Camacci T, Baldini E, Melfi F and Fontanini G. Mutational analysis in cytological specimens of advanced lung adenocarcinoma: A sensitive method for molecular diagnosis. Journal of Thoracic Oncology 2007; 2: 1086-1090.
61. Daniele L, Macri L, Schena M, Dongiovanni D, Bonello L, Armando E, Ciuffreda L, Bertetto O, Bussolati G and Sapino A. Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and Her2 in biopsy and cytology specimens. Mol Cancer Ther 2007; 6: 1223-1229.
62. Nomoto K, Tsuta K, Takano T, Fukui T, Yokozawa K, Sakamoto H, Yoshida T, Maeshima Am, Shibata T, Furuta K, Ohe Y and Matsuno Y. Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis. Am J Clin Pathol 2006; 126: 608-615.
63. Martini N and Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975; 70: 606-612.
64. Oliaro A, Filosso PL, Cavallo A, Giobbe R, Mossetti C, Lyberis P, Cristofori RC and Ruffini E. The significance of intrapulmonary metastasis in non -small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system. Eur J Cardiothorac Surg 2008; 34: 438-443.
65. Trousse D, Barlesi F, Loundou A, Tasei AM, Doddoli C, Giudicelli R, Astoul P, Fuentes P and Thomas P. Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management. J Thorac Cardiovasc Surg 2007;133:1193-1200.
66. Silverman JF, Weaver MD, Shaw R and Newman WJ. Fine needle aspiration cytology of pulmonary infarct. Acta Cytol 1985; 29: 162-166.
67. Lawther RE, Graham AN, McCluggage WG and McGuigan JA. Pulmonary infarct cytologically mimicking adenocarcinoma of the lung. Ann Thorac Surg 2002; 73: 1964-1965.
68. Weaver KM, Novak PM and Naylor B. Vegetable cell contaminants in cytology specimens. Acta Cytol 1981; 25: 210-214.
69. Mizutani E, Tsuta K, Maeshima AM, Asamura H and Matsuno Y. Minute pulmonary meningothelial nodules: clinicopathologic analysis of 121 patients. Hum Pathol 2009; 40: 678-682.
70. Psaras T, Pantazis G, Steger V, Meyermann R, Honegger J and Beschorner R. Benign meningioma developing late lung metastases: case report and review of literature. Clin Neuropathol 2009; 28: 453-459.
71. Adlakha A, Rao K, Adlakha H, Perry A, Crotty TB, Scheithauer BW and Ryu JH. Meningioma metastatic to the lung. Mayo Clin Proc 1999; 74: 1129-1133.
72. Parwani AV, Baisden BL, Erozan YS, Burger PB and Ali SZ. Pineal gland lesions: a cytologic study of 20 specimens. Cancer 2005; 105: 80-86.
73. Parwani AV, Mikolaenko I, Eberhart CG, Burger PC, Rosenthal Dl and Ali SZ. Rhabdoid meningioma: cytopathologic findings in cerebrospinal fluid. Diagn Cytopathol 2003; 29: 297-299.
74. Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, Spitznagel EL and Piccirillo J. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006; 24: 4539-4544.
75. Dowell JE. Small cell lung cancer: are we making progress? Am J Med Sci 2010; 339: 68-76.
76. Renshaw AA, Voytek TM, Haja T and Wilbur DC. Distinguishing small-cell carcinoma from nonsmall cell carcinoma of the lung. Arch Pathol Lab Med 2005; 129: 619-623.
77. Pelosi G, Rodriguez J, Viale G and Rosai J. Typical and atypical pulmonary carcinoid tumor overdiagnosed as small cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients. Am J Surg Pathol 2005; 29: 179-187.
78. Aslan DL, Gulbahce HE, Pambuccian SE, Manivel JC and Jessurun J. Ki-67 immunoreactivity in the differential diagnosis of pulmonary neuroendocrine neoplasm in specimens with extensive crush artifact. Am J Clin pathol 2005; 123: 874-878.
79. Renshaw AA, Haja J, Lozano RL and Wilbur CW. Distinguishing carcinoid tumor from small cell carcinoma of the lung: correlating cytologic features and performance in the College of American Pathologists non-gynecologic cytology program. Arc Pathol Lab Med 2005; 129: 614-618.
80. Laucirica R and Ostrowski ML. Cytology of nonneoplastic occupational and environmental diseases of the lung. Arch Pathol Lab Med 2007; 131: 1700-1708.
81. Arora VK, Singh N, Chaturvedi S and Bhatia A. Significance of cytologic criteria in distinguishing small cell from non-small cell carcinoma of the lung. Acta Cytol 2003; 47: 216-220.
82. Bavikatty NR and Michael CW. Cytologic features of small-cell carcinoma on ThinPrep. Diagn Cytopathol 2003; 29: 8-12.
83. Szyfelbein WM and Ross JS. Carcinoids, atypical carcinoids and small cell carcinoma of the lung: differential diagnosis of fine needle aspiration biopsy specimens. Diagn Cytopathol 1988; 4: 1-8.
84. Collins BT and Cramer HM. Fine needle aspiration of carcinoid tumors. Acta Cytol 1996; 40: 695-707.
85. Mitchell ML and Parker FP. Capillaries: a cytologic feature of pulmonary carcinoid tumors. Acta Cytol 1991; 35: 183-185
86. Flanders E, Kornstein MJ, Wakely PE Jr, Kardos TF and Frable WJ. Lymphoglandular bodies in fine needle aspiration cytology smears. Am J Clin Pathol 1993; 99: 566-569.